Latest Mergers And Acquisitions News

Orange Minerals NL has raised $810,000 to fund exploration and due diligence on its new Tepa Gold Project acquisition in Ghana, while advancing promising Australian projects with notable assay results.

West Coast Silver has raised over $6 million through a share placement to accelerate exploration at its high-grade Elizabeth Hill silver project, signalling strong investor confidence and ambitious growth plans.

EQ Resources Limited highlighted its growing global footprint in tungsten mining at the 2025 Noosa Mining Conference, detailing production growth, reserve expansions, and strategic funding initiatives.

Catalyst Metals reported steady gold production in the June 2025 quarter, progressing development at its Trident project while completing key corporate transactions that strengthen its growth outlook.

Future Battery Minerals Ltd has acquired 100% ownership of the Miriam Project, extinguishing royalties and advancing multiple high-priority gold targets with initial drilling completed. Assay results are expected in early September 2025.

InVert Graphite Limited has successfully raised $3.5 million and resumed ASX trading following key acquisitions and promising initial trench results at its Morogoro Graphite Project.

Bioxyne Limited reports a record-breaking Q4 FY25 with revenue soaring 204% year-on-year and a strategic entry into the German market through a €3.2 million manufacturing agreement.

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

Novonix Limited reports significant progress in its synthetic graphite anode materials production, benefiting from new US tariffs on Chinese imports and strategic leadership appointments. The company also secures up to US$100 million in convertible debenture funding to support expansion plans.

Catalyst Metals has locked in a three-year A$100 million revolving credit facility with major banks, bolstering its financial flexibility without immediate debt drawdown. This move strengthens its balance sheet as it advances development at the Plutonic Gold Belt.

Karoon Energy reported a 25% jump in net revenue interest production for Q2 2025, driven by operational recovery and the Baúna FPSO acquisition. The company also advanced its Neon development with a significant resource upgrade.

Island Pharmaceuticals reported promising Phase 2a/b trial results for its dengue drug ISLA-101 and secured a strategic acquisition of the broad-spectrum antiviral Galidesivir, bolstering its pipeline and balance sheet.